Lirong Meng

563 total citations
25 papers, 435 citations indexed

About

Lirong Meng is a scholar working on Molecular Biology, Cancer Research and Oncology. According to data from OpenAlex, Lirong Meng has authored 25 papers receiving a total of 435 indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Molecular Biology, 10 papers in Cancer Research and 4 papers in Oncology. Recurrent topics in Lirong Meng's work include Cancer-related molecular mechanisms research (6 papers), MicroRNA in disease regulation (4 papers) and Circular RNAs in diseases (4 papers). Lirong Meng is often cited by papers focused on Cancer-related molecular mechanisms research (6 papers), MicroRNA in disease regulation (4 papers) and Circular RNAs in diseases (4 papers). Lirong Meng collaborates with scholars based in Macao, China and Australia. Lirong Meng's co-authors include Chao Shang, Bin Lang, Pedro Fong, Weimin Yao, Hui Zhou, Yu Gan, Xiaoyuan Xu, Xinping Wang, Bin Fu and Yuebo Yang and has published in prestigious journals such as Scientific Reports, Molecules and Experimental Biology and Medicine.

In The Last Decade

Lirong Meng

25 papers receiving 431 citations

Peers

Lirong Meng

ONCOL

SURGE

Maryam Ranjbar Iran

Ya-Jun Yang China

Yaoyao Xie China

Huma Khan India

Eun-Kyung Hong South Korea

Kewei Zhao China

Lijuan Yang China

Buzhen Tan China

Qiuchen Qi China

Maryam Ranjbar Iran

Lirong Meng

418 ×1.4

230 ×1.2

67 ×1.4

ONCOL

28 ×0.7

33 ×1.1

SURGE

Citations per year, relative to Lirong Meng Lirong Meng (= 1×) peers Maryam Ranjbar

Countries citing papers authored by Lirong Meng

Since Specialization

Citations

This map shows the geographic impact of Lirong Meng's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lirong Meng with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lirong Meng more than expected).

Fields of papers citing papers by Lirong Meng

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Lirong Meng. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lirong Meng. The network helps show where Lirong Meng may publish in the future.

Co-authorship network of co-authors of Lirong Meng

This figure shows the co-authorship network connecting the top 25 collaborators of Lirong Meng. A scholar is included among the top collaborators of Lirong Meng based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Lirong Meng. Lirong Meng is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Zhang, Qi, et al.. (2025). Investigating Nurses' Competencies for Development of “Internet + Nursing Service”: A Cross‐Sectional Study. Nursing Open. 12(7). e70275–e70275. 1 indexed citations

Zhang, Qi, Jialing Chen, X.P. Zhu, et al.. (2024). Characterising immune-related adverse events in different types of cancer among Chinese patients receiving immune checkpoint inhibitors. Scientific Reports. 14(1). 30983–30983. 2 indexed citations

Meng, Lirong, Bin Lang, Lifang Li, et al.. (2023). A Cas12a ortholog with distinct TTNA PAM enables sensitive detection of HPV16/18. Cell Reports Methods. 3(4). 100444–100444. 10 indexed citations

Cheang, U Kei, et al.. (2023). Synergistic activity of Coptis Chinensis and clotrimazole against Candida Albicans. Pharmacological Research - Modern Chinese Medicine. 8. 100287–100287. 2 indexed citations

Fong, Pedro, et al.. (2021). Extraction of antibacterial peptides against H. pylori from bovine milk casein. Archives of Medical Science. 18(2). 376–381. 5 indexed citations

Fong, Pedro, et al.. (2020). Effects of Cordycepin, Gold Nanostar, and Their Combination on Endometrial Cancer Cells. Natural Product Communications. 15(8). 1 indexed citations

Gan, Yu, Hui Zhou, Kai Xu, Lirong Meng, & Bin Lang. (2020). [Mir-29c-3p targeting TUG1 affects migration and invasion of bladder cancer cells by regulating CAPN7 expression].. PubMed. 40(9). 1325–1331. 2 indexed citations

Shang, Chao, et al.. (2019). Long Non-coding RNA CDKN2B Antisense RNA 1 Gene Contributes to Paclitaxel Resistance in Endometrial Carcinoma. Frontiers in Oncology. 9. 27–27. 19 indexed citations

Fong, Pedro, et al.. (2019). Antitumor Effects of MRS5698, a Cordycepin Derivative, on Endometrial Cancer Cells. Natural Product Communications. 14(10). 1 indexed citations

10.

Gan, Yu, Hui Zhou, Weimin Yao, Lirong Meng, & Bin Lang. (2019). lncRNA TUG1 Promotes Cisplatin Resistance by Regulating CCND2 via Epigenetically Silencing miR-194-5p in Bladder Cancer. Molecular Therapy — Nucleic Acids. 16. 257–271. 83 indexed citations

11.

Fong, Pedro, et al.. (2019). In Silico and In Vitro Anti-Helicobacter Pylori Effects of Combinations of Phytochemicals and Antibiotics. Molecules. 24(19). 3608–3608. 18 indexed citations

12.

Shang, Chao, et al.. (2017). Long non-coding RNA tumor suppressor candidate 7 advances chemotherapy sensitivity of endometrial carcinoma through targeted silencing of miR-23b. Tumor Biology. 39(6). 3726132388–3726132388. 26 indexed citations

13.

Lang, Bin, Chao Shang, & Lirong Meng. (2016). Targeted Silencing of S100A8 Gene by miR-24 to Increase Chemotherapy Sensitivity of Endometrial Carcinoma Cells to Paclitaxel. Medical Science Monitor. 22. 1953–1958. 17 indexed citations

14.

Xiang, Yu‐Tao, Lirong Meng, & Gábor S. Ungvári. (2015). China to halt using executed prisoners’ organs for transplants: a step in the right direction in medical ethics. Journal of Medical Ethics. 42(1). 10–10. 7 indexed citations

15.

Gao, Meng, Hao Duan, Jing Liu, et al.. (2014). The multi-targeted kinase inhibitor sorafenib inhibits enterovirus 71 replication by regulating IRES-dependent translation of viral proteins. Antiviral Research. 106. 80–85. 24 indexed citations

16.

Fong, Pedro & Lirong Meng. (2014). Effect of mTOR Inhibitors in Nude Mice with Endometrial Carcinoma and Variable PTEN Expression Status. Medical science monitor basic research. 20. 146–152. 20 indexed citations

17.

Shang, Chao, et al.. (2012). MicroRNA-125b down-regulation mediates endometrial cancer invasion by targeting ERBB2. Medical Science Monitor. 18(4). BR149–BR155. 56 indexed citations

18.

Yang, Yuebo, et al.. (2011). EGFR- and AKT-mediated reduction in PTEN expression contributes to tyrphostin resistance and is reversed by mTOR inhibition in endometrial cancer cells. Molecular and Cellular Biochemistry. 361(1-2). 19–29. 15 indexed citations

19.

Shang, Chao, et al.. (2011). KCC1 Gene Advances Cell Invasion Ability by Regulating ERK Signaling Pathway in Endometrial Cancer HEC-1B Cell Line. International Journal of Gynecological Cancer. 21(5). 795–799. 6 indexed citations

20.

Zhang, Shulan, et al.. (2007). [Inhibition of invasive and chemotactic abilities of SKOV3 cells by human epithelial growth receptor-2 small interfering RNA].. PubMed. 42(1). 48–53. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact